Promoting freedom, innovation, and growth

Connect with IPI

Receive news, research, and updates

JANUARY 12, 2018

The Bigger Picture of Why Drugs Cost So Much (Audio: Interview)


In a chat with WINA's Rob Schilling, IPI's Dr. Merrill Matthews discusses the two-fold blow as a result of Pfizer halting work developing new drugs for Alzheimer’s disease and Parkinson’s disease, causing not just a disappointment to those waiting for a cure, but pushing up the costs of other drugs. 


  • TaxBytes-New

Copyright Institute for Policy Innovation 2018. All Rights Reserved Privacy Policy Contact IPI.

e-resources e-resources